| Books and
book chapters
Murphy MF, Pamphilon DH (Eds) (2001) Practical Transfusion Medicine. Blackwell Science, Oxford 2001 Pamphilon DH (2001) Transfusion support in transplant patients. in Practical Transfusion Medicine. Eds M.F.Murphy & D.H. Pamphilon Blackwell Science, Oxford Poole J Blood Group Incompatibility. in Encyclopedia of Life Sciences, Macmillan Reference Limited, London (April 2001) Review Articles and Editorials Daniels G. A century of human blood groups. Wien Klin Wochenschr. 2001 Oct 30;113(20-21):781-6. Kumpel BM & Elson CJ (2001) Mechanism of anti-D-mediated immune suppression - a paradox awaiting resolution? Trends in Immunology, 22:26-31. Scott ML (2001) Monoclonal anti-D for immunoprophylaxis. Vox Sang. 81: 213-218. Baldwin A, Kingman H, Darville M, Foot ABM, Grier D, Cornish JM, Goulden N, Oakhill A, Pamphilon DH, Steward CG, Marks DI (2001) Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation. British Journal of Haematology, 26:1333-1338 Blair A., Rowbottom A.W., Browne S.J., Goulden N.J., Steward C.G., Oakhill A., Pamphilon D.H. An optimised biphasic culture system for the generation of functional dendritic cells from patients with acute lymphoblastic leukaemia at presentation and in clinical remission. Leukemia 2001; 15; 1596-1603 Danek A, Rubio JP, Rampoldi L, Ho M, Dobson-Stone C, Tison F, Symmans WA, Oechsner M, Kalckreuth W, Watt JM, Corbett AJ, Hamdalla HH, Marshall AG, Sutton I, Dotti MT, Malandrini A, Walker RH, Daniels G, Monaco AP. McLeod neuroacanthocytosis: genotype and phenotype. Ann Neurol. 2001 Dec;50(6):755-64. Davoren A, Smith OP, Barnes CA, Lawlor E, Evans RG & Lucas GF (2001). Case report: four donors with granulocyte-specific or HLA class I antibodies implicated in a case of transfusion-related acute lung injury (TRALI). Immunohematology 17 (4), 117-121. Deeg H.J., Amylon M.D., Harris R.E., Collins R., Beatty P.G., Feig S., Ramsay N., Territo M., Khan S.P., Pamphilon D., Leis J.F., Burdach S., Anasetti C., Hackman R., Storer B., Mueller B. Marrow transplants from unrelated donors for patients with aplastic anemia: Minimum effective dose of total body irradiation. Biology of Blood and Marrow Transplantation 2001; 7; 208-215 Engelfriet CP, Reesink HE, Brand A, Palfi M, Popovsky MA, Martin-Vega C, Ribera A, Rouger P, Goldman M, Decary F, Freedman J, Lucas GF, Navarrete C, Neppert J, v. Witzleben-Schurholz E, Lin B & Zupanska B (2001) International Forum: Transfusion-related acute lung injury. Vox Sanguinis 81, 269-283. Fuge R., Bird J.M., Fraser A., Hart D., Hunt L., Cornish J.M., Goulden N., Oakhill A., Pamphilon D.H., Steward C.G., Marks D.I. The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation. British Journal of Haematology 2001; 113; 58-64 Gilbert R.L., Rider J.R., Turton R., Pamphilon D.H. Detection of residual donor leucocytes in leucoreduced red blood cell components using a fluorescence microplate assay. (Journal of Immunological Methods – accepted for publication Jung HH, Hergersberg M, Kneifel S, Alkadhi H, Schiess
R, Weigell-Weber M, Daniels G, Kollias S, Hess K. Kumpel BM. Labeling D+ RBCs for flow cytometric quantification of fetomaternal hemorrhage after the RBCs have been coated with anti-D. Transfusion 2001;41:1059-1063. Legler TJ, Maas JH, Kohler M, Wagner T, Daniels GL, Perco P, Panzer S. RHD sequencing: a new tool for decision making on transfusion therapy and provision of Rh prophylaxis. Transfus Med. 2001 Oct;11(5):383-8. Masson D, Vusio P, Loriat MJ, Spring F, Anstee DJ, Denis MG, Lustenberger P, Blanchard D. Epitope mapping of four novel CD44 monoclonal antibodies using surface plasmon resonance and soluble CD44. Transfusion Medicine 2001, 11, 447-454 Murphy MF, Knetchli C, Downie C, Rogers SE, Lucas GF (2001). Serendipity and the use of random donor platelets in fetomaternal alloimmune thrombocytopenia. British Journal of Haematology, 113, 1077-1078. Parsons SF, Lee G, Spring FA, Willig TN, Peters LL, Gimm JA, Tanner MJ, Mohandas N, Anstee DJ, Chasis JA (2001) Lutheran blood group glycoprotein and its newly-characterized mouse homologue specifically bind alpha 5 chain-containing human laminin with high affinity. Blood, 97:312-320. (View article) Pocock CF, Lucas GF, Giles C, Vassilou G, Cwynarski K, Rezvani K, Apperley JF & Goldman JM (2001). Immune neutropenia associated with anti-human neutrophil antigen-2a (NB1) antibodies following unrelated donor stem cell transplantation for chronic myeloid leukaemia: perpetuation by granulocyte colony-stimulating factor. British Journal of Haematology, 113, 483-485. Smythe J, Anstee DJA (2001) Expression of C antigen in transduced K562 cells. Transfusion, 41:24-30 Soohee Lee, Russo DCW, Reiner AP, Lee JH, Sy MY, Telen MJ, Judd WJ, Simon P, Rodrigues MJ, Chabert T, Poole J, Jovanovic-Srzentic S, Levene C, Yahalom V, Redman CM. Molecular Defects Underlying the Kell Null Phenotype. Journal of Biological Chemistry, 276: 27281-27289 Spring FA, Parsons SF, Ortlepp S, Olsson M, Sessions R, Brady RL, Anstee DJ. (2001) Intercellular adhesion molecule-4 binds a-4-b-1 and a-v family integrins through novel integrin binding mechanisms. Blood 98:458-466 (View article) (View model of ICAM-4) Vassiliou G.S., Webb D.K., Pamphilon D., Knapper S., Veys P.A. Improved outcome of alternative donor bone marrow transplantation in children with severe aplastic anaemia using a conditioning regimen containing low dose total body irradiation, cyclophosphamide and Campath. British Journal of Haematology 2001; 114; 701-705 Willis F, Marsh JCW, Bevan, DH, Killick SB, Lucas G, Griffiths R, Ouwehand W, Hale G, Waldemann H & Gordon-Smith EC (2001). The effect of treatment with Campath-1H in patients with autoimmune cytopenias. British Journal of Haematology, 114, 891-898. Win N, Montgomery J, Sage D, Street M, Duncan J & Lucas G (2001). Recurrent transfusion related acute lung injury. Transfusion 41, 1421 Guidelines and Workshop Reports Daniels GL, Anstee DJ, Cartron JP, Dahr W, Fletcher A, Garratty G, Henry S, Jorgensen J, Judd WJ, Kornstad L, Levene C, Lin M, Lomas-Francis C, Lubenko A, Moulds JJ, Moulds JM, Moulds M, Overbeeke M, Reid ME, Rouger P, Scott M, Sistonen P, Smart E, Tani Y, Wendel S, Zelinski T. International Society of Blood Transfusion Working Party on Terminology for Red Cell Surface Antigens. Vox Sang. 2001 Apr;80(3):193-7. H-G Frank and DW Morrish in cooperation with A Potgens, O Genbacev, B Kumpel and I Cannigia. Cell culture models of human trophoblast: primary culture of trophoblast - a workshop report. Placenta 2001, 22, Supplement A, S107-S109.
Kumpel BM, Jackson DJ. Quantitation of IgG anti-D bound to red cells of normal and weak D phenotype by flow cytometry and IAGT, using a high sensitivity sensitisation protocol and recommended workshop protocols.
(Link to
website) Kumpel BM, Anti-D Quantitation - Comparison of Methods. AABB 54th annual meeting, October 13-17, 2001, Technical/Scientific Compendium, pages 467-475. Blair A, Baker CL, Judson PA. Ex-vivo expansion of megakaryocyte progenitor cells from normal bone marrow and peripheral blood and from patients with haematological malignancies. Blood 98 (11) 646a (abstract) Blair A., Cox C.V., Goulden N.J., Pamphilon D.H., Evely R. Proliferation of clonogenic acute lymphoblastic leukaemia cells in vitro and in vivo. 43rd American Society of Hematology meeting. Florida, December 2001. Blood 2001; 98 (11); p115a Bruce L, Ghosh S, King M-J, Layton M, Delaunay J, Tanner MJ. Severe deficiency of CD47 and reduction of RhAG associated with the absence of protein 4.2 in the red blood cell membrane. Blood 2001, 98, 10a (abstract #28). Corash L., Cazenave J., Van Rhenen D., Gullikksson H., Pamphilon D., Ljungman P., Davis K., Flament J., Marblie S., Conlan M., Lin L., Metzel P., Buchholz D.H. Platelets treated with HELINXÔ technology (HPC) are effective for multiple cycles of transfusion support of thrombocytopenia: the euroSPRITE trial. 54th Annual Meeting of the American Association of Blood Banks. San Antonio, October 2001 (Transfusion. 2001; 41 (Suppl); S133) Evans R, Ferris V, Folman C, von dem Borne A & Lucas G (2001). The rise and fall of thrombopoeitin (TP) in acute lymphopcytic leukaemia (ALL) patients undergoing allogeneic bone marrow transplant (BMT). Transf Med .10, Supplement 1, p24. Jackson DJ, Elson CJ, Kumpel BM. Reduction of human anti-tetanus toxoid responses by tetanus toxoid peptides in a Hu-PBL-SCID mouse model. Transfusion Clinique et Biologique 2001;8 (Suppl 1) page 162s. King M-J and Rogers CA (2001) Involvement of the Rh complex and CD47 in hereditary spherocytosis. British Journal of Haematology 113, Supplement 1, 61 (abstract #229). King M-J, Rogers CA, Smythe J, Mushens R. The Rh complex (Rh30 and RhAG) may have a structural role in the human red cell cytoskeleton. Transfusion Clinique Biologique 2001; 8 (Supplement 1), 38s. Kumpel BM, Goodrick MJ, de Haas M, Koene HR, Westerdaal NAC, van de Winkel JGJ. Clearance or red cells by monoclonal IgG3 anti-D in vivo is influenced by the Fc-g-RIIIA-V/F158 polymorphism. Transfusion Clinique et Biologique 2001;8 (Suppl 1) page 25s. Kumpel B, Manoussaka M. Characterisation of cells in density gradient fractions of trypsinised term placental villi. Placenta 2001;22:A9. MacLennan S, Loh R, Lee E, Williams K, Noble B. Development of a protocol for the production of eyedrops derived from autologous serum. Transfusion Medicine 11, Suppl 1, 40, 2001 Poole J, Davison T, Powell, Hulston M. Anti-Rh51-like in a rare CwDe/CwDe individual. Transfusion Medicine 11 suppl 1:32, 2001 Poole J, Daniels G, Hustinx H, Martin P, Green CA, Warke N, Bromilow I. A novel K allele of the KEL gene. Transfusion 2001;41(suppl):15S. Poole J, Warke N, Shepherd D, Hall C. A C typing problem and observations on the r’’G phenotype. Transfusion Medicine 11 suppl 1;32, 2001 Poole J, Banks J, Schuitemaker L, Straat R, Ligthart P. An unusual Rh40 (Tar+) phenotype causing HDN. Transfusion Medicine 11 suppl 1:33, 2001 Poole J. The screening, identification and use of rare blood. Chinese Journal of Blood Transfusion 14 suppl : 72, 2001 Ridgwell K, Dixey J, Parsons SF, Green CA, Scott ML (2001) Screening human sera for anti-Lu antibodies using soluble recombiant Lu antigens. Transfusion Medicine 11 suppl. 1:2 (abstract). Schlanser G, Ligthart P, Overbeeke M, Davis J, Poole J. First report in North America of allo anti-D in a RoHar individual . Transfusion 41 suppl :105S, 2001 Scott ML (2001) Developments in blood bank technology - past and future. Transfusion Medicine 11 suppl. 1:2 (abstract). Scott ML (2001) Clinical Scientists’ training. Transfusion Medicine 11 suppl. 1:17 (abstract). Singleton BK, Green CA, Kimura K, Minami A, Okuno Y, Daniels GL. Two new RHD mutations associated with the DEL phenotype. Transfus Clin Biol 2001;8(suppl 1):9s. Sintnicolaas K., van Rhenen D., Cazenave J.P., Gulliksson H., Pamphilon D., Ljungman P., Davis K., Conlan M., Lin L., Metzel P., Buchholz D.H., Flament J., Marblie S., Corash L. Clinical refractoriness and HLA alloimmunisation are infrequent after multiple exposures to INTERCEPT platelets. 7th Annual Meeting of the European Congress of the International Society of Blood Transfusion (ISBT). Paris, July 2001 Skinner LH, Guest AR, Mushens RE, Scott ML, Voak D, Avent ND (2001) Involvement of Ser 103 in expression of RH D epitopes. Transfusion Clinique et Biologique 8, suppl 1:9s (abstract). Spring FA, New insights into the function of adhesion molecules on developing and mature erythroid cells. Transfusion Medicine 2001, 11 (suppl 1) 16 (abstract) Warke N Serological Complexities of Rh: a 17-month study. Transfusion Medicine 11 suppl. 1:7, 2001. YS5. |
| Produced for This page was last updated on 14-May-09. |